| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.90M | 81.00M | 86.98M | 73.33M | 112.80M | 52.33M |
| Gross Profit | 59.02M | 44.02M | 54.53M | 39.70M | 68.19M | 19.35M |
| EBITDA | 62.41M | 48.38M | 53.84M | 31.94M | 63.89M | 8.73M |
| Net Income | 33.46M | 22.22M | 27.50M | 10.76M | 38.22M | -26.74M |
Balance Sheet | ||||||
| Total Assets | 358.27M | 333.57M | 318.28M | 326.40M | 349.76M | 334.79M |
| Cash, Cash Equivalents and Short-Term Investments | 94.17M | 80.05M | 63.04M | 74.97M | 98.32M | 88.47M |
| Total Debt | 1.24M | 1.45M | 1.75M | 14.64M | 4.16M | 7.64M |
| Total Liabilities | 59.83M | 59.47M | 63.91M | 93.33M | 95.88M | 103.19M |
| Stockholders Equity | 298.44M | 274.10M | 254.37M | 233.07M | 253.88M | 231.61M |
Cash Flow | ||||||
| Free Cash Flow | 19.70M | 20.06M | 8.42M | 1.07M | 22.55M | 4.50M |
| Operating Cash Flow | 30.46M | 30.82M | 12.54M | 1.16M | 30.14M | 9.23M |
| Investing Cash Flow | -10.71M | -10.74M | -3.79M | -13.74M | 10.19M | -4.72M |
| Financing Cash Flow | -2.82M | -2.10M | -19.68M | -5.84M | -33.37M | -9.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$2.86B | 11.00 | 11.86% | ― | 10.53% | 26.74% | |
61 Neutral | HK$1.72B | 9.28 | 7.57% | 5.71% | 0.59% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | HK$26.29B | 44.00 | 3.30% | ― | 40.31% | 212.50% | |
48 Neutral | HK$592.37M | -16.13 | -14.60% | ― | -44.93% | 30.34% | |
46 Neutral | HK$1.15B | ― | ― | ― | ― | ― | |
45 Neutral | HK$181.98M | -6.19 | 24.24% | ― | -7.90% | 93.34% |
IMAX China Holding, Inc. announced that its controlling shareholder, IMAX Corporation, released its third quarter 2025 financial results and quarterly report. This announcement is significant for stakeholders as it provides insights into the financial health and operational statistics of the parent company, which could impact IMAX China’s market positioning and investor relations. The financial data, prepared under U.S. GAAP, is not directly comparable to IMAX China’s reports, which adhere to IFRS, highlighting potential differences in financial performance metrics.